News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,093 Results
Type
Article (14424)
Company Profile (283)
Press Release (255386)
Section
Business (80604)
Career Advice (173)
Deals (13436)
Drug Delivery (35)
Drug Development (51052)
Employer Resources (32)
FDA (5793)
Job Trends (5308)
News (146404)
Policy (10198)
Tag
Academia (947)
Alliances (22100)
Alzheimer's disease (820)
Antibody-drug conjugate (ADC) (75)
Approvals (5799)
Artificial intelligence (102)
Bankruptcy (102)
Best Places to Work (4739)
Biotechnology (233)
Breast cancer (132)
Cancer (1124)
Cardiovascular disease (89)
Career advice (151)
CAR-T (95)
Cell therapy (276)
Clinical research (41058)
Collaboration (442)
Compensation (184)
COVID-19 (1087)
C-suite (119)
Cystic fibrosis (74)
Data (1166)
Diabetes (106)
Diagnostics (1339)
Earnings (29403)
Events (48249)
Executive appointments (358)
FDA (6313)
Funding (418)
Gene editing (77)
Gene therapy (203)
GLP-1 (340)
Government (1110)
Healthcare (6721)
Infectious disease (1138)
Inflammatory bowel disease (105)
IPO (7327)
Job creations (872)
Job search strategy (144)
Layoffs (198)
Legal (1407)
Lung cancer (167)
Manufacturing (103)
Medical device (2652)
Medtech (2654)
Mergers & acquisitions (6350)
Metabolic disorders (317)
Neuroscience (1137)
NextGen: Class of 2025 (2069)
Non-profit (889)
Northern California (1352)
Obesity (166)
Opinion (98)
Parkinson's disease (90)
Patents (86)
People (25688)
Phase I (14462)
Phase II (19096)
Phase III (12107)
Pipeline (511)
Postmarket research (870)
Preclinical (6055)
Radiopharmaceuticals (210)
Rare diseases (253)
Real estate (1446)
Regulatory (8568)
Research institute (974)
Series A (82)
Southern California (1194)
Startups (2027)
United States (10681)
Vaccines (197)
Weight loss (96)
Date
Today (5)
Last 7 days (346)
Last 30 days (1483)
Last 365 days (20665)
2025 (2682)
2024 (20847)
2023 (22725)
2022 (27522)
2021 (28782)
2020 (23892)
2019 (16723)
2018 (12066)
2017 (14004)
2016 (12044)
2015 (14599)
2014 (10535)
2013 (7653)
2012 (7702)
2011 (7783)
2010 (7566)
Location
Africa (155)
Asia (17421)
Australia (2928)
California (3069)
Canada (973)
China (273)
Colorado (117)
Connecticut (135)
Delaware (72)
Europe (37540)
Florida (349)
Georgia (93)
Illinois (193)
Indiana (78)
Maryland (397)
Massachusetts (2428)
Minnesota (123)
New Jersey (777)
New York (844)
North Carolina (482)
Northern California (1352)
Ohio (101)
Pennsylvania (583)
South America (211)
Southern California (1194)
Texas (349)
Washington State (293)
270,093 Results for "domain therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer
Domain Therapeutics today announces the appointment of Sean A. MacDonald as its Chief Executive Officer (CEO).
April 17, 2024
·
3 min read
Genetown
Domain Therapeutics Strengthens Its Intellectual Property for Its Series of Treg Depleting anti-CCR8 Antibodies, Including Best-in-class Candidate DT-7012
Domain Therapeutics today announces the publication of three international PCT patent applications.
June 6, 2024
·
2 min read
Domain Therapeutics to Participate at Premier Investor and Healthcare Conferences
Domain Therapeutics announced its President and Chief Executive Officer, Anthony Johnson, M.D., and its Chief Business Officer, Sean A. MacDonald, will participate in the following investor, partnering and healthcare industry conferences in April-May, 2024: This press release features multimedia.
April 8, 2024
·
2 min read
Press Releases
Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company
September 30, 2024
·
8 min read
Business
Domain Therapeutics Promotes Stephan Schann as Chief Scientific Officer (CSO)
Domain Therapeutics today announces the expansion of the Company’s executive management team with the appointment of Stephan Schann as Chief Scientific Officer (CSO).
February 27, 2024
·
3 min read
Press Releases
Leveragen Announces Strategic Collaboration with Moonlight Bio to Advance T Cell Therapies Using Proprietary Fully Human Single-Domain Antibody Technology
January 29, 2025
·
3 min read
Business
Domain Therapeutics Further Strengthens Leadership Team With Appointment of Sean A. MacDonald as Chief Business Officer
Domain Therapeutics today announces the appointment of Sean A. MacDonald as its Chief Business Officer (CBO) and member of the executive management team.
February 8, 2024
·
3 min read
Biotech Bay
OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
OmniAb, Inc. announced the publication of a peer-reviewed paper titled “Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies” in the Journal of Immunology demonstrating that chickens can be genetically engineered to produce functional heavy chain-only single-domain antibodies.
June 3, 2024
·
6 min read
Domain Therapeutics to Present Latest Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology, at AACR 2024 Annual Meeting, Highlighting Clear Competitive Advantages of This Candidate
Domain Therapeutics (“Domain” or “the Company”) today announces that latest preclinical data on DT-9045, a novel protease-activated receptor 2 (PAR2) Negative Allosteric Modulator candidate, will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, California.
March 26, 2024
·
4 min read
Press Releases
Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting
November 12, 2024
·
6 min read
1 of 27,010
Next
